Yahoo
NasdaqGM - Nasdaq Real Time Price USD

TScan Therapeutics, Inc. (TCRX)

0.1870 +0.0054 (+2.93%)
As of 1:31:02 PM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-116,280 -135,319 -110,822 -61,358 -66,503
Cash Flow from Investing Activities
46,870 109,372 -52,613 -60,759 -4,225
Cash Flow from Financing Activities
172 -336 208,765 135,443 29,356
Cash and Cash Equivalents, End of Period
105,187 157,437 183,720 138,390 125,064
Cash Flow, Supplemental
Free Cash Flow to Firm
-104,123 -118,979 -116,048 -78,351 -59,322
Capital Expenditure, Calculated
2,159 4,407 3,825 3,146 4,225
Issuance of Capital Stock
0 0 33,131 42,414 193
Repurchase of Capital Stock
0 0 0 0 0
12/31/2022 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: